Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Glucosamine 6-phosphate is a phosphorylated derivative of glucosamine and an intermediate in the hexosamine biosynthesis pathway. It is produced from fructose-6-phosphate and glutamine by the enzyme glutamine—fructose-6-phosphate aminotransferase (GFAT), catalyzing the first step in hexosamine metabolism[1][3]. This small molecule plays a key role as a precursor for glycosaminoglycans and other amino sugars essential for cellular structure and function. While it has not been developed or approved as a pharmaceutical drug or dietary supplement itself[1], it is important in basic metabolic processes within cells.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on glucosamine 6-phosphate.